Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

Jul 24 - Markets closed

World markets

Shanghai 2,105.06 +26.57 (1.28%)
S&P 500 1,987.10 +0.09 (0.00%)
Nikkei 225 15,284.42 -44.14 (-0.29%)
Hang Seng Index 24,141.50 +169.63 (0.71%)
TSEC 9,527.54 +28.18 (0.30%)
EURO STOXX 50 3,220.07 +26.94 (0.84%)
CAC 40 4,410.65 +34.33 (0.78%)
S&P TSX 15,401.38 +7.00 (0.05%)
S&P/ASX 200 5,587.80 +11.10 (0.20%)
BSE Sensex 26,271.85 +124.52 (0.48%)
TA25 1,398.24 +1.77 (0.13%)
KOSPI 2,026.62 -1.70 (-0.08%)
SMI 8,637.01 +31.91 (0.37%)
ATX 2,372.87 -3.73 (-0.16%)
IBOVESPA 58,060.31 +640.35 (1.12%)
SET 1,543.92 +2.36 (0.15%)
BIST100 83,824.65 +970.03 (1.17%)
IBEX 10,860.70 +201.60 (1.89%)
WIG 51,613.47 +72.66 (0.14%)
TASI 10,214.73
MERVAL 6,874.40 +101.39 (1.50%)

Currencies

GBP/USD 1.6984 -0.0056 (-0.33%)
GBP/EUR 1.2617 -0.0039 (-0.31%)
GBP/JPY 172.9400 -0.1300 (-0.08%)
GBP/HKD 13.1628 -0.0437 (-0.33%)
GBP/CNY 10.5217 -0.0405 (-0.38%)
GBP/AUD 1.8039 -0.0007 (-0.04%)
Balfour Beatty and Carillion in �3bn merger talks
Balfour Beatty, the UK's biggest construction company, is in talks with rival Carillion about a potential �3.05bn merger. One source said that talks between the two sides are at a "medium" stage but there are still key terms of the combination to be decided on.
Balfour And Carillion In �3bn Merger Talks  
UK's Balfour Beatty and Carillion in $5.1 billion merger talks: report  
Market Chart
6,821.46 +23.31 (0.34%)
15,748.69 +22.73 (0.14%)
3,634.44 +11.24 (0.31%)
3,313.14 +1.22 (0.04%)

Top stories

(Adds Blanchard quotes on markets, Russia) WASHINGTON/MEXICO CITY, July 24 (Reuters) - The International Monetary Fund on Thursday chopped its 2014 forecast for global economic growth to take into account weakness early in the year in the United ...
Embattled British car parts supplier Unipart Automotive has gone into administration just weeks after it scrambled to secure a rescue deal.
Shares in Kingfisher, the owner of B&Q, tumbled by 8pc on Thursday after the DIY retailer reported falling sales across Europe.
LONDON (Reuters) - GlaxoSmithKline (GSK.L) faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's email reviewed by Reuters.
... * Bank says lawsuit fails to identify any fraud. * No victims, harm or material misstatements established - Barclays (Adds Schneiderman statement, paragraph 5, additional byline and dateline).

Trends

Popular searches on GoogleChange Mkt Cap
MPLE Maple Energy plc 144.44% 36.11M
HWDN Howden Joinery Group Plc 12.52% 2,266.45M